OTC Pharmaceuticals in Asia-Pacific
Datamonitor, November 2010, Pages: 42
The OTC Pharmaceuticals in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of OTC Pharmaceuticals in Asia-Pacific’s recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of OTC Pharmaceuticals in Asia-Pacific
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by both value and volume
- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
- Market shares are covered by manufacturer and/or brand
- Also features market breakdown by distribution channel
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).
For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.
EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
Novartis AG
GlaxoSmithKline Plc
MARKET DISTRIBUTION
MARKET FORECASTS
Market value forecast
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting
LIST OF TABLES
Table 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2005–09
Table 2: Asia-Pacific OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Asia-Pacific OTC pharmaceuticals market segmentation II: % share, by value, 2009
Table 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2009
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: Novartis AG: key facts
Table 9: Novartis AG: key financials ($)
Table 10: Novartis AG: key financial ratios
Table 11: GlaxoSmithKline Plc: key facts
Table 12: GlaxoSmithKline Plc: key financials ($)
Table 13: GlaxoSmithKline Plc: key financials (£)
Table 14: GlaxoSmithKline Plc: key financial ratios
Table 15: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2009
Table 16: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2009–14
LIST OF FIGURES
Figure 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2005–09
Figure 2: Asia-Pacific OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 3: Asia-Pacific OTC pharmaceuticals market segmentation II: % share, by value, 2009
Figure 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2009
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2009
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: GlaxoSmithKline Plc: revenues & profitability
Figure 16: GlaxoSmithKline Plc: assets & liabilities
Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2009–14
- Nin Jiom
- Novartis AG
- Pfizer Inc
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
